CN112401844A - Injection vital sign monitoring method, system and storage medium - Google Patents
Injection vital sign monitoring method, system and storage medium Download PDFInfo
- Publication number
- CN112401844A CN112401844A CN202011289257.5A CN202011289257A CN112401844A CN 112401844 A CN112401844 A CN 112401844A CN 202011289257 A CN202011289257 A CN 202011289257A CN 112401844 A CN112401844 A CN 112401844A
- Authority
- CN
- China
- Prior art keywords
- lead
- patient
- electroencephalogram
- acquiring
- electrocardiogram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002347 injection Methods 0.000 title claims abstract description 66
- 239000007924 injection Substances 0.000 title claims abstract description 66
- 238000000034 method Methods 0.000 title claims abstract description 42
- 238000012544 monitoring process Methods 0.000 title claims abstract description 41
- 239000003814 drug Substances 0.000 claims abstract description 43
- 239000007788 liquid Substances 0.000 claims abstract description 43
- 230000002159 abnormal effect Effects 0.000 claims abstract description 17
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 claims abstract description 11
- 230000033764 rhythmic process Effects 0.000 claims abstract description 8
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 22
- 206010003119 arrhythmia Diseases 0.000 claims description 7
- 230000006793 arrhythmia Effects 0.000 claims description 7
- 238000004590 computer program Methods 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 5
- 230000000241 respiratory effect Effects 0.000 abstract description 7
- 210000001061 forehead Anatomy 0.000 description 6
- 230000000694 effects Effects 0.000 description 3
- 208000001871 Tachycardia Diseases 0.000 description 2
- 208000006218 bradycardia Diseases 0.000 description 2
- 230000036471 bradycardia Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000006794 tachycardia Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physiology (AREA)
- Pulmonology (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
The application relates to the field of medical monitoring equipment, in particular to an injection vital sign monitoring method, a system and a storage medium, wherein the technical scheme is that the relevant information of a patient is obtained; connecting each lead wire to each part of the body of the patient, acquiring electrocardiosignals, electroencephalogram signals and respiratory information of the patient, generating a lead electrocardiogram according to the electrocardiosignals, generating a lead electroencephalogram according to the electroencephalogram signals, and generating a respiratory waveform according to the respiratory information; judging whether the waveforms displayed by the lead electrocardiogram and the lead electroencephalogram are normal or not, injecting liquid medicine into the body of the patient when the waveforms displayed by the lead electrocardiogram and the lead electroencephalogram are normal, and recording the injection time; judging whether the waveforms displayed by the lead electrocardiogram and the lead electroencephalogram after the patient injects the liquid medicine are normal or not, and giving an alarm if the waveform rhythm displayed by the lead electrocardiogram is changed or the waveforms displayed by the lead electroencephalogram are abnormal. Thereby being convenient for finding the change of the state of illness of the patient in time.
Description
Technical Field
The present application relates to the field of medical monitoring devices, and in particular, to an injection vital sign monitoring method, system and storage medium.
Background
In the process of monitoring and treating a severe patient, the injection of liquid medicine is usually needed to adjust the physical condition, but medical care personnel are needed to observe the physical condition of the patient after the liquid medicine is injected, the patient is measured at regular time, the reaction of the patient to the liquid medicine is judged, and when abnormity occurs, a specialist is informed to perform treatment in time.
However, in actual care, the labor intensity of medical care personnel is high, and when a large number of patients exist, the medical care personnel can easily ignore slight changes of the patients, so that the medical care personnel are not favorable for finding the changes of the illness state of the patients in time.
Disclosure of Invention
In order to facilitate timely finding of the change of the patient's condition, the application provides an injection vital sign monitoring method, system and storage medium.
In a first aspect, the present application provides an injection vital sign monitoring method, which adopts the following technical scheme:
an injection vital signs monitoring method, comprising:
acquiring relevant information of a patient;
connecting each lead wire to each part of the body of the patient, acquiring an electrocardiosignal and an electroencephalogram signal of the patient, generating a lead electrocardiogram according to the electrocardiosignal, and generating a lead electroencephalogram according to the electroencephalogram signal;
judging whether the waveforms displayed by the lead electrocardiogram and the lead electroencephalogram are normal or not, injecting liquid medicine into the body of the patient when the waveforms displayed by the lead electrocardiogram and the lead electroencephalogram are normal, and recording the injection time;
judging whether the waveforms displayed by the lead electrocardiogram and the lead electroencephalogram after the patient injects the liquid medicine are normal or not, and giving an alarm if the waveform rhythm displayed by the lead electrocardiogram is changed or the waveforms displayed by the lead electroencephalogram are abnormal.
By adopting the technical scheme, the electrocardiosignals and the electroencephalograms of the patient before and after injection are detected in real time, the lead electrocardiogram and the lead electroencephalogram before injection are displayed on a computer screen, when the waveforms displayed by the lead electrocardiogram and the lead electroencephalogram before injection are normal, the liquid medicine is injected into the patient, and the probability that the illness state of the patient is aggravated by the injection of the liquid medicine when the body of the patient is abnormal is effectively reduced;
after the patient injects the liquid medicine, acquire the ECG and the EEG that leads after injecting the liquid medicine, the medical personnel of being convenient for in time know the health condition after the patient injects the liquid medicine, when patient's health appears unusually, medical personnel in time press the warning light in patient ward to be convenient for supply the doctor in time to handle.
Optionally, the method further includes:
acquiring a lead electrocardiogram of a patient, and acquiring the heart rate of the patient according to heart rate sensing leads;
the heart rate sensing lead is one of lead lines which are connected with the body of a patient and used for acquiring electrocardiosignals.
By adopting the technical scheme, when the electrocardiogram with leads is obtained, the heart rate of the patient is obtained, and the condition of the patient can be further accurately judged.
Optionally, before acquiring the heart rate of the patient according to the heart rate sensing lead, the injection vital sign monitoring method further includes:
acquiring the position of R wave in a lead electrocardiogram acquired by heart rate sensing leads, calculating all adjacent RR intervals based on the position of the R wave, and giving an alarm if the difference value of the RR intervals is greater than a preset threshold value a, wherein the arrhythmia is caused; if the difference value of the RR intervals is smaller than or equal to a preset threshold value a, acquiring the heart rate g of the patient;
wherein the heart rate of the patient is g =60/RR interval, and the RR interval is the time limit between two R waves on the electrocardiogram with leads.
By adopting the technical scheme, before the heart rate of the patient is acquired, whether the patient is arrhythmia is judged at first, and if the patient is arrhythmia, the patient needs to be timely treated, so that the physical condition of the patient can be conveniently detected.
Optionally, the method further includes:
when the waveform display of the lead electrocardiogram is normal and the heart rate is abnormal, the heart rate sensing lead is changed, and the lead with larger waveform amplitude is selected.
By adopting the technical scheme, when the waveform display of the lead electrocardiogram is normal and the heart rate is abnormal, the heart rate sensing lead needs to be reselected, so that the heart rate of the patient can be accurately measured, and the physical condition of the patient can be accurately judged.
Optionally, the method further includes:
the method comprises the steps of acquiring electrocardiosignals and electroencephalogram signals of a patient, monitoring the respiration of the patient through the change of the temperature of the breathing gas and generating a respiration waveform.
By adopting the technical scheme, the electrocardiosignal, the electroencephalogram signal and the respiration signal of the patient are acquired simultaneously, so that the physical condition of the patient can be further accurately known.
Optionally, the method further includes:
acquiring a screenshot instruction, and acquiring data displayed at the current moment according to the screenshot instruction to generate a screenshot picture;
placing the screenshot picture in a preset screenshot canvas;
and generating a final screenshot picture by taking the frame of the screenshot canvas as a boundary, and storing and printing the final screenshot picture.
By adopting the technical scheme, the waveform before injection and the waveform after injection are intercepted and printed, so that the analysis and diagnosis of a follow-up doctor are facilitated.
In a second aspect, the present application provides an injection vital sign monitoring system, which adopts the following technical solution:
an injection vital signs monitoring system, comprising:
the input module is used for inputting relevant information of a patient;
the data acquisition module is used for acquiring electrocardiosignals and electroencephalogram signals of a patient;
the control module is used for receiving the electrocardiosignals and the electroencephalogram signals sent by the data acquisition module, generating corresponding lead electrocardiograms according to the received electrocardiosignals and generating lead electroencephalograms according to the received electroencephalogram signals;
the display module is used for receiving and displaying the lead electrocardiogram and the lead electroencephalogram sent by the control module and displaying an operation interface;
the processing module is used for injecting liquid medicine into the body of the patient when the lead electrocardiogram and the lead electroencephalogram are in normal states;
the display module is used for displaying a lead electrocardiogram and a lead electroencephalogram after liquid medicine is injected, judging whether the waveforms displayed by the lead electrocardiogram and the lead electroencephalogram after the liquid medicine is injected by a patient are normal or not, and giving an alarm if the waveform rhythm displayed by the lead electrocardiogram is changed or the waveforms displayed by the lead electroencephalogram are abnormal.
By adopting the technical scheme, the electrocardiosignals and the electroencephalograms of the patient before and after injection are detected in real time, the lead electrocardiogram and the lead electroencephalogram before injection are displayed on a computer screen, when the waveforms displayed by the lead electrocardiogram and the lead electroencephalogram before injection are normal, the liquid medicine is injected into the patient, and the probability that the illness state of the patient is aggravated by the injection of the liquid medicine when the body of the patient is abnormal is effectively reduced;
after the patient injects the liquid medicine, acquire the ECG and the EEG that leads after injecting the liquid medicine, the medical personnel of being convenient for in time know the health condition after the patient injects the liquid medicine, when patient's health appears unusually, medical personnel in time press the warning light in patient ward to be convenient for supply the doctor in time to handle.
Optionally, the method further includes:
the control module is used for generating a respiratory waveform according to the received respiratory signal and sending the respiratory waveform to the display module for displaying.
By adopting the technical scheme, the electrocardiosignal, the electroencephalogram signal and the respiration signal of the patient are acquired simultaneously, so that the physical condition of the patient can be further accurately known.
In a third aspect, the present application provides an intelligent terminal, which adopts the following technical scheme:
an intelligent terminal comprising a memory and a processor, said memory having stored thereon a computer program that can be loaded by the processor and executed to perform the above described method of injection vital signs monitoring.
By adopting the technical scheme, the corresponding program can be stored and processed, and the effect of timely knowing the change of the state of an illness of the patient is convenient to achieve.
In a fourth aspect, the present application provides a computer-readable storage medium, which adopts the following technical solutions:
a computer readable storage medium storing a computer program that can be loaded by a processor and executed, for example, to perform an infusion vital signs monitoring method.
By adopting the technical scheme, the corresponding program can be stored, and the effect of timely knowing the change of the state of an illness of the patient is convenient to achieve.
In summary, the present application includes at least one of the following beneficial technical effects:
1. by detecting electrocardiosignals and electroencephalograms of a patient before and after injection in real time and displaying a lead electrocardiogram and a lead electroencephalogram before injection on a computer screen, when waveforms displayed by the lead electrocardiogram and the lead electroencephalogram before injection are normal, liquid medicine is injected into the patient, so that the probability of aggravating the illness state of the patient due to liquid medicine injection when the body of the patient is abnormal is effectively reduced; when a patient injects a liquid medicine, a lead electrocardiogram and a lead electroencephalogram after the liquid medicine is injected are obtained, so that medical staff can know the body condition of the patient after the liquid medicine is injected in time, and when the body of the patient is abnormal, the medical staff can press down an alarm lamp in a patient ward in time, so that the patient can conveniently and timely handle the alarm lamp;
2. the electrocardiosignal and the electroencephalogram signal of the patient are obtained, and meanwhile, the respiratory signal of the patient is obtained, so that the physical condition of the patient can be further accurately known.
Drawings
Fig. 1 is a block flow diagram of an injection vital signs monitoring method according to an embodiment of the present application.
Fig. 2 is a display interface shown in an embodiment of the present application.
Fig. 3 is another flow chart diagram of an injection vital signs monitoring method according to an embodiment of the present application.
Fig. 4 is a flow chart of an injection vital signs monitoring system shown in an embodiment of the present application.
Description of reference numerals: 1. an input module; 2. a data acquisition module; 3. a control module; 4. a display module; 5. a processing module; 6. and a breath collection module.
Detailed Description
The present application is described in further detail below with reference to figures 1-4.
The embodiment of the application discloses an injection vital sign monitoring method. Referring to fig. 1, an injection vital signs monitoring method comprises the steps of:
s10, acquiring relevant information of the patient;
the user inputs the relevant information of the patient through the computer and stores the relevant information, wherein the relevant information of the patient comprises the name, the sex, the age or the birth date of the patient and the illness state of the patient.
S11, connecting each lead wire to each part of the body of the patient, acquiring electrocardiosignals and electroencephalogram signals of the patient by a monitor, sending the electrocardiosignals and the electroencephalogram signals to a computer, generating and displaying a lead electrocardiogram by the computer according to the electrocardiosignals, and generating and displaying a lead electroencephalogram according to the electroencephalogram signals;
specifically, 3 lead wires for acquiring electrocardiosignals are provided, wherein the lead wire I is a left-hand and right-hand difference, the lead wire II is a right-hand and left-foot difference, the lead wire III is a left-hand and left-foot difference, and the waveform amplitudes of the 3 lead wires are different; the number of lead wires for acquiring the electroencephalogram signals is 2, wherein the lead wires 1-11 are connected with the left forehead of the left ear, and the lead wires 2-12 are connected with the right forehead of the right ear. The lead wires are connected with the lead wire interface of the monitor, and the monitor is connected with the USB port of the computer through the USB connecting wire.
When sampling is started, electrocardiogram of I, II, III leads and electroencephalogram of 2 leads on forehead are displayed on the computer screen, and when electroencephalogram of forehead is not selected, electrocardiogram of 3 leads is displayed on the computer screen. If a certain lead waveform appears on the computer screen and is displayed as a straight line or has interference, the electrode and the connecting lead are required to be immediately checked whether the electrode and the connecting lead are loosened or not and whether the electrode is in good contact with the skin or not.
S12, judging whether the waveforms displayed by the lead electrocardiogram and the lead electroencephalogram are normal or not, injecting liquid medicine into the body of the patient when the waveforms displayed by the lead electrocardiogram and the lead electroencephalogram are normal, and recording the injection time;
if a certain lead waveform appears on the computer screen and is displayed as a straight line or has interference, whether the electrode and the connecting lead are loosened or not and whether the electrode is in good contact with the skin or not need to be immediately checked.
S13, judging whether the waveforms displayed by the lead electrocardiogram and the lead electroencephalogram after the patient injects the liquid medicine are normal, and if the waveform rhythm displayed by the lead electrocardiogram is changed or the waveform displayed by the lead electroencephalogram is abnormal, giving an alarm.
Wherein the rhythm change includes tachycardia and bradycardia, and tachycardia means heart rate more than 100 times per minute, and bradycardia means heart rate less than 60 times per minute. Abnormalities in the waveform displayed by the lead electroencephalogram include the appearance of abnormal excitatory waves or a significant reduction in agitation.
Specifically, electrocardiosignals and electroencephalograms of a patient before and after injection are detected in real time, a lead electrocardiogram and a lead electroencephalogram before injection are displayed on a computer screen, and when waveforms displayed by the lead electrocardiogram and lead electroencephalogram before injection are normal, liquid medicine is injected into the patient, so that the probability that the condition of the patient is aggravated by the injection of the liquid medicine when the body of the patient is abnormal is effectively reduced.
After the patient injects the liquid medicine, acquire the ECG and the EEG that leads after injecting the liquid medicine, the medical personnel of being convenient for in time know the health condition after the patient injects the liquid medicine, when patient's health appears unusually, medical personnel in time press the warning light in patient ward to be convenient for supply the doctor in time to handle.
Referring to fig. 2, the injection vital signs monitoring method further comprises:
acquiring a lead electrocardiogram of a patient, and acquiring a heart rate g of the patient according to a heart rate sensing lead;
the heart rate sensing lead is one of lead lines which are connected with the body of a patient and used for acquiring electrocardiosignals, and the heart rate sensing lead is defaulted to be a lead line II.
Injecting the vital signs monitoring method prior to acquiring the heart rate of the patient from the heart rate sensing leads further comprises:
acquiring the position of R waves in a lead electrocardiogram acquired by heart rate sensing leads according to a slope method, calculating all adjacent RR intervals based on the positions of the R waves, and giving an alarm if the difference value of the RR intervals is greater than a preset threshold value a, wherein the arrhythmia is caused; if the difference value of the RR intervals is smaller than or equal to a preset threshold value a, acquiring the heart rate g of the patient;
wherein the heart rate of the patient is g =60/RR interval, and the RR interval is the time limit between two R waves on the electrocardiogram with leads.
Specifically, the slope method is set as: all wave crests of the upper half part of the ECG are obtained, and the R wave crest is limited and detected by the slopes of the left side and the right side of the wave crest, so that the position of the R wave can be obtained.
And the preset threshold a can be set to be 0, if all RR intervals are not equal, arrhythmia is detected, and at the moment, an alarm is sent out, so that doctors can process the arrhythmia in time. A normal RR interval time limit is typically between 0.6-1.0 seconds, and assuming an average RR interval of 1 second, the patient's heart rate is g =60/1=60 times/minute, and the patient's heart rate is within the normal range.
When the waveform of the lead electrocardiogram is displayed normally and the heart rate is abnormal, the heart rate sensing lead is changed, and the lead I or the lead III with larger waveform amplitude is selected.
The injection vital signs monitoring method further comprises:
the method comprises the steps of acquiring electrocardiosignals and electroencephalogram signals of a patient, monitoring the respiration of the patient through the change of the temperature of the breathing gas and generating a respiration waveform.
Particularly, the thermosensitive probe is fixed at the upper lip nasal cavity outlet part of the patient, the breathing of the patient is sensed by monitoring the temperature change of the breathing gas, the probability that the patient cannot monitor the breathing when the waveform of the lead electrocardiogram is disordered is effectively reduced, and the condition of the patient can be further known conveniently.
With reference to fig. 2 and 3, the injection vital signs monitoring method further comprises the steps of:
s20, acquiring a screenshot instruction, and acquiring data displayed at the current moment according to the screenshot instruction to generate a screenshot picture;
specifically, when a waveform before injection needs to be intercepted, a normal waveform before injection is selected, then a button for intercepting the waveform before injection on a computer screen is clicked, a screenshot command is sent to the computer through the click button, and after the computer receives the screenshot command, content data displayed on the current computer screen is obtained and a screenshot picture is generated;
when the injected waveform needs to be intercepted, the injected waveform is selected, then an intercepted waveform button on a computer screen is clicked, a screenshot command is sent to the computer through the click button, and after the computer receives the screenshot command, content data displayed on the current computer screen is obtained and a screenshot picture is generated; .
S21, placing the screenshot picture in a preset screenshot canvas;
the computer is internally stored with a preset screenshot canvas, and the size of the preset screenshot canvas is the same as that of the computer screen.
And S22, generating a final screenshot picture by taking the frame of the screenshot canvas as a boundary, storing the final screenshot picture in a computer, and sending the stored final screenshot picture to a printer by the computer for printing.
Specifically, the waveforms before and after injection are intercepted and printed, so that a doctor can conveniently analyze and diagnose.
The embodiment of the present application further discloses an injection vital sign monitoring system, referring to fig. 4, including:
the input module 1 is used for inputting relevant information of a patient;
the user inputs the relevant information of the patient through the computer and stores the relevant information, wherein the relevant information of the patient comprises the name, the sex, the age or the birth date of the patient and the illness state of the patient.
The data acquisition module 2 is used for acquiring electrocardiosignals and electroencephalogram signals of a patient;
specifically, the data acquisition module 2 is provided with lead wires connected with the monitor, the lead wires are connected to human body surface electrodes of the monitored patient, 3 lead wires for acquiring electrocardiosignals are provided, wherein the lead wire I is a left-hand and right-hand difference, the lead wire II is a right-hand and left-foot difference, the lead wire III is a left-hand and left-foot difference, and the waveform amplitudes of the 3 lead wires are different; the number of lead wires for acquiring the electroencephalogram signals is 2, wherein the lead wires 1-11 are connected with the left forehead of the left ear, and the lead wires 2-12 are connected with the right forehead of the right ear.
The control module 3 is used for receiving the electrocardiosignals and the electroencephalogram signals sent by the data acquisition module 2, generating corresponding lead electrocardiograms according to the received electrocardiosignals and generating lead electroencephalograms according to the received electroencephalogram signals;
specifically, the control module 3 is set as a computer, and the monitor is connected to a USB interface of the computer through a USB connecting wire.
The display module 4 is used for receiving and displaying the lead electrocardiogram and the lead electroencephalogram sent by the control module 3 and displaying an operation interface;
the processing module 5 is used for injecting liquid medicine into the body of the patient when the lead electrocardiogram and the lead electroencephalogram are in normal states;
specifically, the processing module 5 is set as an injection pump, and the injection pump is connected with the computer through wireless communication. When the lead electrocardiogram and the lead electroencephalogram are both in a normal state, medical personnel send signals to the control module 3 through an operation interface on a computer, the control module 3 controls the injection pump to start after receiving the signals, liquid medicine is injected into a patient, and meanwhile, the control module 3 records the injection time. After the injection of the liquid medicine is finished, the control module 3 controls the injection pump to stop, so that the accuracy of the injection time is ensured, and meanwhile, the tightness and the accuracy in the injection process are ensured.
After the injection of the liquid medicine is finished, the display module 4 is used for displaying the lead electrocardiogram and the lead electroencephalogram after the liquid medicine is injected, medical staff judges whether the waveforms displayed by the lead electrocardiogram and the lead electroencephalogram after the liquid medicine is injected by a patient are normal or not, and when the waveform rhythm displayed by the lead electrocardiogram changes or the waveforms displayed by the lead electroencephalogram are abnormal, the medical staff timely presses down an alarm lamp in a patient ward, so that a specialist is reminded of timely treating the patient.
The injection vital signs monitoring system further comprises:
and the breath acquisition module 6 is used for acquiring a breath signal of a patient and sending the breath signal to the control module 3, and the control module 3 is used for generating a breath waveform according to the received breath signal and sending the breath waveform to the display module 4 for display.
Specifically, the breath collection module 6 is a heat sensitive probe, which is fixed to the upper lip and nasal cavity outlet of the patient, and is used for monitoring the temperature change information of the breathing gas, sending the temperature change information to the computer to generate a breath waveform, and displaying the breath waveform through the display module 4. Even when the ambient temperature is close to the body temperature of a human body, because a large amount of water vapor is contained in the exhaled air, the temperature change which can be detected is still generated between breaths due to the heat release of the condensation of the steam and the heat absorption of the evaporation of trace condensed water, thereby being convenient for accurately detecting the breathing signal.
The embodiment of the application also discloses an intelligent terminal which comprises a memory and a processor, wherein the memory is stored with a computer program which can be loaded by the processor and can execute the injection vital sign monitoring method.
An embodiment of the present application further discloses a computer-readable storage medium storing a computer program capable of being loaded by a processor and executing the injection vital sign monitoring method, the computer-readable storage medium comprising: u disk, removable hard disk, read only memory, optical disk, etc. various media that can store program code.
The above embodiments are preferred embodiments of the present application, and the protection scope of the present application is not limited by the above embodiments, so: all equivalent changes made according to the structure, shape and principle of the present application shall be covered by the protection scope of the present application.
Claims (10)
1. An injection vital sign monitoring method, comprising:
acquiring relevant information of a patient;
connecting each lead wire to each part of the body of the patient, acquiring an electrocardiosignal and an electroencephalogram signal of the patient in real time, generating a lead electrocardiogram according to the electrocardiosignal, and generating a lead electroencephalogram according to the electroencephalogram signal;
judging whether the waveforms displayed by the lead electrocardiogram and the lead electroencephalogram are normal or not, injecting liquid medicine into the body of the patient when the waveforms displayed by the lead electrocardiogram and the lead electroencephalogram are normal, and recording the injection time;
judging whether the waveforms displayed by the lead electrocardiogram and the lead electroencephalogram after the patient injects the liquid medicine are normal or not, and giving an alarm if the waveform rhythm displayed by the lead electrocardiogram is changed or the waveforms displayed by the lead electroencephalogram are abnormal.
2. An injection vital signs monitoring method as claimed in claim 1, further comprising:
acquiring a lead electrocardiogram of a patient, and acquiring the heart rate of the patient according to heart rate sensing leads;
the heart rate sensing lead is one of lead lines which are connected with the body of a patient and used for acquiring electrocardiosignals.
3. An injected vital signs monitoring method as claimed in claim 2, wherein the injected vital signs monitoring method further comprises, prior to acquiring the heart rate of the patient from the heart rate sensing leads:
acquiring the position of R wave in a lead electrocardiogram acquired by heart rate sensing leads, calculating all adjacent RR intervals based on the position of the R wave, and giving an alarm if the difference value of the RR intervals is greater than a preset threshold value a, wherein the arrhythmia is caused; if the difference value of the RR intervals is smaller than or equal to a preset threshold value a, acquiring the heart rate g of the patient;
wherein the heart rate of the patient is g =60/RR interval, and the RR interval is the time limit between two R waves on the electrocardiogram with leads.
4. An injection vital signs monitoring method as claimed in claim 2, further comprising:
when the waveform display of the lead electrocardiogram is normal and the heart rate is abnormal, the heart rate sensing lead is changed, and the lead with larger waveform amplitude is selected.
5. An injection vital signs monitoring method as claimed in claim 1, further comprising:
the method comprises the steps of acquiring electrocardiosignals and electroencephalogram signals of a patient, monitoring the respiration of the patient through the change of the temperature of the breathing gas and generating a respiration waveform.
6. An injection vital signs monitoring method as claimed in claim 1, further comprising:
acquiring a screenshot instruction, and acquiring data displayed at the current moment according to the screenshot instruction to generate a screenshot picture;
placing the screenshot picture in a preset screenshot canvas;
and generating a final screenshot picture by taking the frame of the screenshot canvas as a boundary, and storing and printing the final screenshot picture.
7. An injection vital signs monitoring system, comprising:
an input module (1) for inputting information relating to a patient;
the data acquisition module (2) is used for acquiring electrocardiosignals and electroencephalogram signals of a patient in real time;
the control module (3) is used for receiving the electrocardiosignals and the electroencephalogram signals sent by the data acquisition module (2), generating corresponding lead electrocardiograms according to the received electrocardiosignals and generating lead electroencephalograms according to the received electroencephalogram signals;
the display module (4) is used for receiving and displaying the lead electrocardiogram and the lead electroencephalogram sent by the control module (3) and displaying an operation interface;
the processing module (5) is used for injecting liquid medicine into the body of the patient when the lead electrocardiogram and the lead electroencephalogram are in normal states;
the display module (4) is used for displaying a lead electrocardiogram and a lead electroencephalogram after liquid medicine is injected, judging whether the waveforms displayed by the lead electrocardiogram and the lead electroencephalogram after the liquid medicine is injected by a patient are normal or not, and giving an alarm if the waveform rhythm displayed by the lead electrocardiogram is changed or the waveforms displayed by the lead electroencephalogram are abnormal.
8. An injection vital signs monitoring system as claimed in claim 7, further comprising:
the respiration acquisition module (6) is used for acquiring respiration signals of a patient and sending the respiration signals to the control module (3), and the control module (3) is used for generating respiration waveforms according to the received respiration signals and sending the respiration waveforms to the display module (4) for displaying.
9. The utility model provides an intelligent terminal which characterized in that: comprising a memory and a processor, said memory having stored thereon a computer program which can be loaded by the processor and which performs the method according to any of claims 1-6.
10. A computer-readable storage medium characterized by: a computer program which can be loaded by a processor and which executes the method according to any of claims 1-6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011289257.5A CN112401844A (en) | 2020-11-17 | 2020-11-17 | Injection vital sign monitoring method, system and storage medium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011289257.5A CN112401844A (en) | 2020-11-17 | 2020-11-17 | Injection vital sign monitoring method, system and storage medium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112401844A true CN112401844A (en) | 2021-02-26 |
Family
ID=74832177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011289257.5A Pending CN112401844A (en) | 2020-11-17 | 2020-11-17 | Injection vital sign monitoring method, system and storage medium |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112401844A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103598874A (en) * | 2013-10-11 | 2014-02-26 | 深圳市深迈医疗设备有限公司 | Vital sign and infusion state monitoring system |
| CN105582590A (en) * | 2014-10-24 | 2016-05-18 | 万军 | Intelligent diagnosis and treatment injection system |
| CN111773491A (en) * | 2020-06-24 | 2020-10-16 | 刘海红 | Transfusion chair capable of intelligently sensing vital signs of patient |
-
2020
- 2020-11-17 CN CN202011289257.5A patent/CN112401844A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103598874A (en) * | 2013-10-11 | 2014-02-26 | 深圳市深迈医疗设备有限公司 | Vital sign and infusion state monitoring system |
| CN105582590A (en) * | 2014-10-24 | 2016-05-18 | 万军 | Intelligent diagnosis and treatment injection system |
| CN111773491A (en) * | 2020-06-24 | 2020-10-16 | 刘海红 | Transfusion chair capable of intelligently sensing vital signs of patient |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11647939B2 (en) | System and method for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer | |
| US11826151B2 (en) | System and method for physiological data classification for use in facilitating diagnosis | |
| US11647941B2 (en) | System and method for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer | |
| CA2871608C (en) | Hemodynamic reserve monitor and hemodialysis control | |
| CA2978636C (en) | Display arrangement for diagnosis of cardiac rhythm disorders | |
| US20100204552A1 (en) | Apparatus for monitoring biological information | |
| EP3654347A1 (en) | A system and method for personalized monitoring of life-threatening health conditions in patients with chronic kidney disease | |
| CN116965774A (en) | Intraoperative anesthesia state monitoring equipment | |
| EP3488772B1 (en) | Ecg data classification for use in facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer | |
| CN108601535A (en) | Index output equipment, exponent output method and index output program | |
| CN116829061A (en) | Monitoring device and method for determining accuracy of pulse pressure variation degree | |
| CN107928660B (en) | Health early warning system based on electrocardiogram | |
| CN204484105U (en) | A kind of cardiovascular real-time remote monitoring device | |
| CN112401844A (en) | Injection vital sign monitoring method, system and storage medium | |
| CN116669630A (en) | Monitoring information display method, electroencephalogram abnormality alarm method and monitoring system | |
| WO2021030216A1 (en) | Facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer | |
| CN116999038A (en) | Monitoring equipment | |
| CN111938609A (en) | Automatic blood vessel disease detection equipment | |
| CN114743348A (en) | Multifunctional monitoring device for intelligently judging over ventilation based on electrocardiosignals | |
| CN114190906A (en) | Physiological parameter monitoring equipment and monitoring method thereof | |
| CN111297471A (en) | Display of arrhythmia type | |
| Paria et al. | CardioPi: An Innovative Embedded System for Real-Time ECG Monitoring and Heart Health Management | |
| Devi et al. | Informatics in Medicine Unlocked |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210226 |